Dr. Stephen R Gundry study: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning (8th November) https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712
Measurement of multiple protein biomarkers, which generates a score predicting the 5 year risk (percentage chance) of a new Acute Coronary Syndrome Score is based on changes from the norm of multiple protein biomarkers, IL-16, (a proinflammatory cytokine)
https://pubmed.ncbi.nlm.nih.gov/10857846/ Soluble Fas, (an inducer of apoptosis) https://journals.physiology.org/doi/full/10.1152/ajpheart.00777.2002
FasL is the ligand adenoviral overexpression of FasL Hepatocyte Growth Factor (serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue) https://www.sciencedirect.com/topics/neuroscience/hepatocyte-growth-factor Among other markers Elevation above the norm increases the PULS score Decreases below the norm lowers the PULS score
The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.
This report summarizes those results A total of 566 patients, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot.
At the time of this report, these changes persist for at least 2.5 months post second dose of vac. We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.
Dr. Stephen R Gundry
Seems you entered wrong password click here to enter password again.